- If approved, MOGENRY® would be the first disease-agnostic treatment for patients with inherited retinal dystrophies (IRDs)

- PMDA has accepted the application and the file will be reviewed on Priority, building on the Sakigake and Orphan drug designations granted to MOGENRY for IRDs in Japan

- Application is supported by positive RESTORE Phase 2b/3 and long-term follow-up data in Retinitis Pigmentosa and STARLIGHT Phase 2 data in Stargardt disease

DALLAS, Oct. 1, 2026 /PRNewswire/ -- Nanoscope Therapeutics, Inc. ("Nanoscope"), a biotechnology company focused on developing and commercializing novel, disease–agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accepted for review, and granted priority review to, the Company's New Drug Application (NDA) seeking marketing approval from the Ministry of Health, Labour and Welfare (MHLW) of MOGENRY®(sonpiretigene isteparvovec, MCO-010), an optogenetic gene therapy designed for vision restoration, for the treatment of inherited retinal dystrophies (IRDs).

Priority review reflects MOGENRY's designation under the Sakigake Designation System, Japan's expedited regulatory pathway for innovative medical products, and is intended to shorten the time to a regulatory decision. Separately, the U.S. Food and Drug Administration (FDA) has accepted and filed the Company's Biologics License Application (BLA) for MOGENRY for the treatment of retinitis pigmentosa (RP) with severe vision loss, which remains under review.

"The PMDA's acceptance of our application with priority review is a pivotal moment for Nanoscope and for the many patients living with IRDs who have no approved treatment options today," said Sulagna Bhattacharya, Chief Executive Officer of Nanoscope Therapeutics. "With MOGENRY now under priority review in both Japan and the United States, with potential approvals in both markets expected in the first half of 2027, we are advancing our goal of making a one-time, disease-agnostic vision-restoring therapy available to patients across major markets. The strength of our RESTORE data and the durability observed in long-term follow-up in the REMAIN study reinforce our confidence in MOGENRY's potential, and we look forward to working closely with the PMDA and MHLW throughout the review process."

The application is supported by positive efficacy and safety data from the Phase 1/2a trial in RP (NCT04919473), the RESTORE Phase 2b/3 multicenter, randomized, double-masked, sham-controlled clinical trial in RP (NCT04945772), and the STARLIGHT multicenter, Phase 2 trial in Stargardt disease (NCT05417126). RESTORE met its primary and key secondary endpoints, demonstrating improvements in visual acuity at weeks 52 and 76. MOGENRY was well tolerated, with no treatment-related serious adverse events reported. Most patients dosed in RESTORE have continued into the REMAIN study, which provides long-term follow-up data included in the submission.

"We designed MCO-010 to act downstream of the genetic defect, so that a single therapy could restore vision in ambient lighting conditions regardless of which of the hundreds of genes is driving a patient's disease," said Samarendra Mohanty, Ph.D., Co-Founder, President and Chief Scientific Officer of Nanoscope Therapeutics. "We are very encouraged by the continued constructive and collaborative dialogue with the Japanese regulators over the past 1 year. Seeing the PMDA accept our NDA across IRDs and grant it priority review, on the strength of MCO-010's unique mechanism of action and clinical evidence, is incredibly exciting for our entire team. It reflects our conviction that vision restoration does not have to be limited to a single gene or a single disease, and we are proud to be one step closer to bringing MOGENRY to IRD patients who have been waiting for a treatment. Each regulatory milestone renews our commitment to moving with urgency for people living with IRDs worldwide."

If approved, MOGENRY would become the first disease-agnostic therapy in Japan to improve vision in patients with IRDs, offering a one-time, in-office treatment that does not require genetic testing or administration in a surgical suite.

About Inherited Retinal Dystrophies

Inherited retinal dystrophies (IRDs) are a genetically diverse group of rare disorders, caused by mutations in more than 250 genes, in which progressive loss of photoreceptor cells leads to impaired vision and, in most cases, complete blindness. IRDs include retinitis pigmentosa (RP), the most common IRD, as well as Stargardt disease, cone-rod dystrophies, and Leber congenital amaurosis, among others. Because gene-specific therapies address only a single genetic cause, the vast majority of patients with IRDs have no approved treatment option. In Japan, IRD is one of the leading causes of visual impairment, and RP is designated as an intractable disease.

About MOGENRY (sonpiretigene isteparvovec; MCO-010)

Nanoscope's multi-characteristic opsin (MCO) technology utilizes a proprietary genetically engineered synthetic opsin to enable optimized performance in terms of high light sensitivity across a broad spectrum and fast kinetics. After Nanoscope's Co-Founder, President, and Chief Scientific Officer, Samarendra Mohanty, envisioned and invented the technology, his team has spent over a decade evaluating its performance across multiple animal models and human diseases. MOGENRY is an investigational, one-time, in-office, intravitreal optogenetic gene therapy built on Nanoscope's MCO platform. By delivering a multi-characteristic opsin gene to the highly dense bipolar retinal cells, MOGENRY makes these surviving cells directly light-sensitive, enabling them to utilize the remaining visual circuitry following photoreceptor loss. MOGENRY does not require genetic testing, invasive surgery, or repeat dosing, and is designed for administration within existing retina office workflows. MOGENRY is under review by the FDA for the treatment of RP with severe vision loss and under priority review by the PMDA and MHLW for the treatment of IRDs in Japan.

About Nanoscope Therapeutics

Nanoscope Therapeutics is developing disease-agnostic, vision-restoring optogenetic therapy for millions of patients blinded by retinal degenerative diseases. Following positive results from the RESTORE Phase 2b/3 multicenter, randomized, double-masked, sham-controlled clinical trial for RP (NCT04945772), the FDA has accepted and filed the Company's BLA for MOGENRY, and the PMDA has accepted for priority review the Company's NDA for MOGENRY for the treatment of IRDs in Japan. If approved, MOGENRY has the potential to become the standard of care for patients with RP and other IRDs, administered as a one-time, in-office injection without the need for genetic testing. The Company has also shown promising results in the STARLIGHT Phase 2 clinical trial of MCO-010 in Stargardt disease (SD) (NCT05417126) and plans to initiate a Phase 3 registrational trial in 2026. MCO-010 has received FDA Fast Track and Orphan Drug designations for both RP and SD, along with RMAT designation for SD, and EMA Orphan designations covering non-syndromic and syndromic rod- and cone-dominant dystrophies, as well as macular dystrophies. MCO-010 has also received Sakigake and Orphan designations for inherited retinal dystrophies (IRDs) in Japan and an Orphan designation for IRDs in Saudi Arabia. A Phase 2 program for MCO in geographic atrophy is expected to start in 2026, and other IND-ready programs include Leber congenital amaurosis (LCA). Learn more at NanosTherapeutics.com and follow @NSTherapeutics on X and on LinkedIn.

Media

Nanoscope Therapeutics, Inc.

(817) 857-1186

[email protected]

SOURCE Nanoscope Therapeutics

Share this article

AeroCore Technologies Opens Middle East Headquarters in Riyadh, Saudi Arabia

Patented one-hour foam wash technology, delivered at the gate, will bring measurable performance, availability and fuel efficiency benefits to operators across Saudi Arabia and the GCC.

RIYADH, Saudi Arabia, Oct. 1, 2026 /PRNewswire/ -- AeroCore Technologies, inventor of Nucleated Foam Technology™ aircraft engine cleaning, today opened its Middle East regional headquarters in Riyadh. From Riyadh, AeroCore will help airlines across Saudi Arabia and the GCC recover engine performance, reduce fuel burn and keep engines on wing longer in some of the world's most demanding operating conditions.

The headquarters will be home to regional leadership, engineering, technician training and equipment support, building local capability and placing service teams closer to customers across the Kingdom and the GCC, in support of Saudi Vision 2030.

Designed for Gulf operating conditions

Heat, humidity, dust and sand challenge aircraft engine performance in the Middle East. Gas path fouling erodes exhaust gas temperature margin, increases fuel burn and pressures time on wing. Operators are experiencing accelerated engine removals and need a better on-wing cleaning solution.

AeroCore's patented technology has been field-proven across thousands of washes on U.S. military aircraft in some of the world's harshest environments. It cleans the full engine gas path planeside in about an hour, without disassembly or towing. Multiple engines can be washed at once, and all effluent is captured for environmentally responsible disposal. The process fits a data-driven engine wash program into overnight maintenance or planned ground time.

AeroCore's commercial programs have reported EGT margin recovery of approximately 4–10°C beyond legacy wash methods, fuel burn reductions of 0.5–1.5%, and time-on-wing extensions of up to 1,500 cycles.

Validated aircraft families widely operated across the GCC include the Airbus A320 and A321 families, A330 and A350, and Boeing 737 NG and MAX, 777 and 787.

"Saudi Arabia and the GCC are building one of the world's most ambitious aviation markets, and that growth needs solutions that improve availability, extend time on wing and build local capability. Our Riyadh headquarters brings that capability closer to operators, on their ramps and around their schedules," said Captain Fahd Cynndy, Board Member, AeroCore Technologies.

About AeroCore Technologies

AeroCore Technologies, a leader in aircraft engine cleaning solutions, holds over 20 international patents. Combined with AeroCore's Total Engine Health™ engine-by-engine monitoring, these solutions enhance asset availability and readiness, reduce lifecycle costs and minimize maintenance hours. AeroCore now operates at 21 airports and military bases across the US and globally, with an expanding footprint in Brazil, Japan and the Middle East.

Beyond aviation, AeroCore applies Nucleated Foam Technology™ to land-based and aeroderivative turbines, and serves the oil and gas and power sectors through its joint venture, ReNu Technologies, which focuses on air-cooled heat exchangers, heat recovery steam generators (HRSG), steam turbines, liquefied natural gas (LNG) assets and other power-generation equipment. For more information about ReNu Technologies, visit www.renutech.com or contact [email protected].

Learn more at https://aerocore.com or contact [email protected].

Cleanest on the ground, longest in the sky™.

SOURCE AeroCore Technologies

Share this article

Ribbon-cutting opens Kerry's first Pennsylvania manufacturing site, which significantly expands coffee extraction capacity

BETHLEHEM, Pa., Oct. 1, 2026 /PRNewswire/ -- Kerry, a global leader in taste and sustainable nutrition, has officially opened its state-of-the-art coffee extraction facility in Bethlehem, Pennsylvania, the company's first manufacturing site in the state. Kerry marked the opening on September 30 with a ribbon-cutting ceremony that brought together customers, industry partners, government representatives, and community leaders for guided facility tours and product tastings.

With plans first announced in September 2025, the site is dedicated to developing natural coffee taste and flavor profiles using advanced extraction and concentration technologies to create premium coffee solutions tailored to each customer's formulation, from ready-to-drink (RTD) coffee beverages to alcoholic drinks, ice cream and savory sauces. The facility increases Kerry's overall coffee extraction capabilities significantly, with independent hot and cold brew extraction lines designed to scale as demand grows.

"The opening of our Bethlehem facility is an important milestone for our coffee business in North America," said John Cahalane, President & CEO of Kerry North America. "It brings additional capacity and advanced processing capabilities closer to customers on the East Coast, helping them respond quickly to changing consumer preferences across hot and cold coffee. Just as importantly, it gives us greater flexibility to develop high-quality coffee experiences while identifying opportunities to reduce supply chain complexity and environmental impact."

"Pennsylvania is open for business, and we are thrilled to welcome Kerry's major investment to the Lehigh Valley," added Rick Siger, Secretary of the Pennsylvania Department of Community and Economic Development (DCED). "This state-of-the-art facility drives local job creation and economic growth in Bethlehem while also positioning Pennsylvania at the forefront of modern, efficient food manufacturing."

Serving Record Demand for Premium Coffee

The Bethlehem facility opens as U.S. demand for premium coffee continues to grow. According to new data from the National Coffee Association, 48% of American adults drank specialty coffee in the past day, outpacing traditional coffee (39%), and setting a record high. Furthermore, dunnhumby's 2026 coffee trends analysis of more than 50 million shoppers finds consumers moving to higher-quality coffee, including RTD formats, despite rising prices. With taste driving competition in branded coffee, the new facility enables Kerry's customers to deliver premium, fresh-brewed flavor that remains shelf-stable without refrigeration.

Advanced Coffee Extraction and Production Capabilities

To help brands meet that demand, the facility applies Kerry's proprietary extraction and thermal processing technologies, including:

- Premium, Tailored Coffee Profiles: Advanced roasting, extraction, concentration and processing technologies that enable Kerry to craft natural, formulation-specific coffee ingredients with consistent, true-to-bean flavor and aroma.

- Cost Efficiency and Menu Versatility: Allows foodservice operators to launch full craft coffee programs – including iced lattes, espresso-style drinks, cold brew and functional beverages – without barista training or capital investment in equipment.

- Built to Scale Using Lower-Carbon Operations: Expansion-ready production capabilities allow Kerry to increase output as customer demand grows, while High-Brix concentration (23–30 Brix) and ambient shipping cut water transport and carbon versus refrigerated alternatives.

- 61% lower carbon when using Direct Concentrated Fresh (DCF) beans.

- 40% lower carbon compared to competitor conventional coffee offerings.

- 34% lower carbon compared to refrigerated Brix products.

The Bethlehem facility will use natural, sustainably sourced ingredients aligned with USDA Organic, Fairtrade, Rainforest Alliance and Café Femenino standards that support producer communities and environmental stewardship. Kerry's Beyond the Horizon commitment actively champions certified, ethical and sustainable sourcing standards and developing solutions that are Better for People, Planet and Society.

About Kerry

Kerry is a global leader in taste and nutrition solutions. We innovate with our customers to create great-tasting products, with improved nutrition and functionality, while ensuring a better impact on the planet. Our leading consumer insights, global RD&A team of 1,300 scientists, and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and will reach over two billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.

SOURCE Kerry Group

Share this article

PHILADELPHIA, Oct. 1, 2026 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) today announced that Joseph (Joe) Mitchell, MD, has officially assumed the role of President and Chief Executive Officer, ushering in a new chapter for the nation's first children's hospital. Dr. Mitchell succeeds Madeline Bell, who retired after nearly four decades of service to CHOP, including 11 years as CEO.

A nationally recognized healthcare leader with more than 20 years of experience in pediatric healthcare, strategy and organizational leadership, Dr. Mitchell brings a strong track record of advancing quality, innovation and patient-centered care. He joined CHOP as President in April 2025 and has spent the past 18 months working closely with CHOP leadership, clinicians, researchers, staff and community partners in preparation for this transition.

"Every day, CHOP's teams make a profound difference for children and families facing their most challenging moments," said Dr. Mitchell. "I am excited to work alongside our teams as we continue advancing breakthrough research, expanding access to care, and delivering the best possible outcomes for children and families. The future is incredibly bright for CHOP and the patients we serve."

Dr. Mitchell previously served as Executive Vice President at Boston Children's Hospital and President of Franciscan Children's, where he led significant strategic growth initiatives, including securing city and state approvals for a 10-year institutional master plan and a new state-of-the-art hospital facility scheduled to open in 2029. He also launched a major capital campaign to support campus modernization and future growth.

Earlier in his career, Dr. Mitchell spent 14 years at McKinsey & Company, including seven years as a Partner, advising healthcare organizations on strategy, operations and transformation. A physician by training, he trained in the Harvard urology residency program at Brigham and Women's Hospital and completed a National Institutes of Health-sponsored research fellowship at the University of California, San Francisco.

Since joining CHOP, Dr. Mitchell has worked alongside leaders across the organization to advance key strategic priorities, strengthen CHOP's regional presence, and deepen engagement with employees, patients, families, donors and community stakeholders.

Founded more than 170 years ago, CHOP remains committed to addressing the most complex challenges in pediatric healthcare through world-class patient care, groundbreaking research, education and advocacy. Under Dr. Mitchell's leadership, the organization will continue investing in innovative care models, scientific discovery, and the future of pediatric medicine.

Contact: Dan Alt, [email protected]

SOURCE Children's Hospital of Philadelphia

Share this article

Baptist Health Care and PAM Health Expand Joint Venture Vision

PENSACOLA, Fla., Oct. 1, 2026 /PRNewswire/ -- Baptist Health Care and PAM Health are collaborating to address rapid growth and increasing demand for health care services across Northwest Florida and South Alabama. This updated partnership will bring 40 new acute care beds on the campus of Baptist Hospital and 60 new inpatient rehabilitation beds to Baptist Medical Park – Nine Mile. The enhanced bed capacity is a direct response to the increasing community need for inpatient acute care and inpatient rehabilitation beds in our region.

Under the new approach, PAM Health and Baptist Health Care will develop a freestanding 60-bed inpatient rehabilitation hospital on the Baptist Medical Park – Nine Mile campus, providing expanded capacity for specialized rehabilitation services. Baptist Hospital will retain the planned space in the Henderson Health Center, which will be converted into a 40-bed acute care hospital unit.

"Our commitment to the Pensacola community has only grown stronger," said Anthony Misitano, founder, chairman and chief executive officer, PAM Health. "When Baptist Health Care identified an urgent need for additional acute care capacity, we recognized an opportunity to think bigger. A freestanding, 60-bed hospital allows us to design a rehabilitation hospital without space constraints, featuring state-of-the-art therapy gyms and robust clinical programs that will serve as a true destination for patients recovering from serious injury or illness."

The addition of beds at the Baptist Hospital campus comes at a time when the need for inpatient care in the local area is increasingly high. The expanded unit will help provide care for more patients and support the growing health needs of the community.

"Our community has a very clear need for additional inpatient acute care beds. This collaboration with PAM Health allows us to address critical capacity needs at Baptist Hospital while investing together in a bigger vision for the rehabilitation needs of our community," said Brett Aldridge, executive vice president and chief operating officer, Baptist Health Care. "By expanding both inpatient capacity and rehabilitation services, we are creating greater access to high-quality care for our growing region. We are grateful for a partner whose mission and values align with our commitment to serving this community."

The new inpatient acute care beds at Baptist Hospital are expected to be available in the coming months. Additional details and timelines for the inpatient rehabilitation hospital at the Baptist Medical Park – Nine Mile campus will be announced soon.

Summary Bullets for Reporter Reference:

- Baptist Health Care and PAM Health are expanding their joint venture partnership.

- The updated agreement revises a plan announced in early 2025.

- The original plan called for a 40-bed inpatient rehabilitation hospital within the Henderson Health Center on the Baptist Hospital campus.

- The revised plan includes development of a new freestanding 60-bed inpatient rehabilitation hospital on the Baptist Medical Park – Nine Mile campus.

- The new rehabilitation hospital will increase capacity for specialized inpatient rehabilitation services.

- Baptist Hospital will retain the planned space in the Henderson Health Center.

- The retained space will be converted into a new 40-bed acute care unit at Baptist Hospital.

- Baptist Hospital's bed count will increase from 279 to 319.

- The new acute care beds at Baptist Hospital are expected to open later this year.

- Details and timelines for the rehabilitation hospital will be announced in the coming months.

About Baptist Health Care

Baptist Health Care is a not-for-profit health care organization based in Northwest Florida that is committed to helping people throughout life's journey. Baptist continuously strives to be a national leader in quality and service. Baptist Health Care includes three hospitals, four medical parks, Andrews Institute for Orthopaedics & Sports Medicine and a large network of primary care and specialty physicians. Baptist Health Care is one of the largest non-governmental employers in Northwest Florida.

About PAM Health

PAM Health, based in Enola, Pennsylvania, provides post-acute healthcare services through more than 100 long-term acute care hospitals, medical rehabilitation hospitals, behavioral health hospitals, as well as wound care clinics and outpatient physical therapy locations, in 23 states. PAM Health is committed to providing high-quality patient care and outstanding customer service, coupled with loyal, dedicated, and highly trained staff, to be the most trusted and impactful source for healthcare services in every community it serves. Learn more at PAMHealth.com.

SOURCE PAM Health

Share this article

Bahrain to Convene Architects of the Future Economy for Gateway Gulf's Fourth Edition This November

At a pivotal moment for the global economy, international leaders will engage in open dialogue to explore how partnerships and cross-border investment can catalyse sustainable growth and strengthen economic resilience.

MANAMA, Bahrain, Oct. 1, 2026 /PRNewswire/ -- Bahrain is set to convene an exclusive gathering of ministerial and senior government officials, visionary chief executives, and influential voices from across the Middle East, Asia, Europe, Latin America, and North America, for the fourth edition of Gateway Gulf, taking place from 1-2 November 2026 at the Four Seasons Hotel Bahrain Bay under the theme Reimagining Global Partnerships, Powering Sustainable Growth.

Hosted by the Bahrain Economic Development Board (Bahrain EDB), the invitation-only forum will explore how shifting dynamics are transforming investment, capital flows, innovation, and economic collaboration across borders. As geopolitical landscapes evolve, energy systems transition, and technological change accelerates, the forum will examine the strategic relationships, connectivity corridors, and emerging opportunities that will define the future of the world economy.

With a combined economy exceeding USD 2.38 trillion, the Gulf Cooperation Council (GCC) has cemented its position as a nexus for capital, talent, and innovation, demonstrating resilience through sustained investment in infrastructure, regional integration, and economic diversification. Serving as a gateway to the region, Bahrain offers a highly connected, business-friendly ecosystem and a diversified economy in which non-oil sectors contribute 86% of GDP, positioning the island nation as a compelling destination for businesses and investors seeking to scale, invest and capture long-term opportunities across one of the world's most dynamic economic regions.

Together with representatives from Bahrain's public and private sectors, 200 senior decision-makers will take part in two days of high-level dialogue, executive engagement, and dealmaking. This year's programme will feature curated networking opportunities, private meetings, and investment showcases designed to foster meaningful partnerships and tangible outcomes. Discussions will explore the evolving landscape of global capital flows and economic connectivity, the Gulf's expanding role in shaping global growth, the industries defining the next era of competitiveness, and the rise of the intelligence economy. Collectively, these conversations will examine how governments, investors, and businesses can strengthen resilience and unlock new pathways for collaboration in an increasingly interconnected and complex global environment.

Building on its track record as a catalyst for investment and cross-border economic collaboration, the forum has consistently translated dialogue into action, facilitating landmark investment announcements and strategic agreements. The 2025 edition alone generated more than USD 17 billion in announced transactions and investment commitments, reinforcing its role in accelerating capital deployment and contributing to shaping the region's economic future. Previous editions have welcomed prominent speakers including H.E. Shaikh Salman bin Khalifa Al Khalifa, Minister of Finance and National Economy of the Kingdom of Bahrain; H.E. Noor bint Ali Alkhulaif, Minister of Sustainable Development, Chief Executive of Bahrain EDB; H.E. Ahmed Al-Khateeb, Minister of Tourism of the Kingdom of Saudi Arabia; H.E. Dr. Thani Ahmed Al Zeyoudi, Minister of State for Foreign Trade of the United Arab Emirates; Lubna S. Olayan, Chair of the Corporate Board of The Olayan Group; Andrea C. Bonomi, Chairman of the Industrial Advisory Board at Investindustrial; Sir Alastair King, DL, His Majesty's Lord-Lieutenant of Greater London; Sir Jonathan Symonds CBE, Chair of the Board of GSK; Mohammad Abunayyan, Founder & Chairman of the Board of Directors of ACWA Power; Tony Fernandes, CEO of Capital A Berhad & AirAsia Berhad; Martin Gilbert, Chairman of Revolut; and Gabriel Escarrer, Chairman & CEO of Meliá Hotels International.

SOURCE Bahrain EDB

Share this article

Beyond's Horizons launch bundles more than 40 other product and feature updates into one release, giving property managers and hosts the tools they need to grow revenue, price with confidence, and save time.

SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Beyond, the short-term rental industry's leading revenue management platform, announces three major new features: Owner Hub, Advanced Connectivity, and Performance Manager, designed to help property managers and hosts stay ahead of their competition and grow their short-term rental business. Alongside these major updates, Beyond's October 2026 Horizons product release includes over 40 product and feature updates across Beyond's pricing algorithm, Insights dashboard, integrations functionality, and user workflows.

"For too long, growing a short-term rental business has meant winning owner trust by instinct and finding performance problems by digging through spreadsheets," said Gerard Murphy, Chief Product Officer. "This release changes both. Owner Hub gives property managers a real toolset to win owners, report to them, and defend performance when the market turns. Performance Manager shows them exactly where a portfolio is underperforming, down to the market and bedroom count, so the fix is a click away instead of a hunt. Together, they're providing our customers value they can see, prove, and act on every day."

Owner Hub: winning, reporting to, and defending performance for owners

Owner Hub brings three existing features, Owner Projections, Listing Lens, and Owner Reports, into a single experience that simplifies how users manage owner relationships inside Beyond.

- Owner Projections turns any global address or listing URL into three scenario-based revenue projections that a property manager can send an owner the same day, with an editable comp set and no PMS connection required.

- Listing Lens provides a prioritized, concrete fix list for a listing's photos, amenities, and content, so property managers spend less time guessing and get every listing revenue-ready faster.

- Owner Reports (formerly Owner Insights) delivers owner-ready reporting with market context and an editable AI summary, so customers can proactively explain a soft month to an owner with all the relevant data included in an easily built report.

The functionality within Owner Hub can save property managers significant time: running a projection for one listing drops from 60 minutes to 1 minute, reviewing a listing with Listing Lens drops from 30 minutes to 1 minute, and building an owner report drops from 20 minutes to 2 minutes, adding up to hours saved each month for a property management company.

"It has greatly improved owner communication. They can now see their personal statistics year to year, and it helps back us up when we need to have difficult discussions regarding a homeowner's property," says Amber Donevant, Revenue & Implementations Manager at Carolina One Vacation Rentals.

Advanced Connectivity: opening Beyond's data to a customer's own systems

Advanced Connectivity gives customers API and MCP server access to Beyond's pricing, performance, and market data, so their own AI assistant can act on Beyond directly instead of just answering questions about it. A customer can ask their assistant to:

- Make a change: adjust a base price or minimum price by a number or a percentage ("drop base price 10% on my Destin 3-bedrooms"),

- Set a minimum stay, add a rate override, or build a group or saved filter across one listing or many at once, targeted by name, market, bedroom count, or status.

- Pull real data in volume: listings, calendars, reservations, performance, pacing, market data, and settings history, so customers can build their own reports directly in the tools they already use.

Guardrails are built in to ensure that all automations and speed never eliminate user control. Write access is a separate permission the customer grants explicitly; nothing happens without approval, changes can be previewed before they're committed, and every edit runs through the same bulk-edit system as Beyond's in-app editor, so it's visible and reversible. The assistant only sees and does what the user can, and every call is logged.

Performance Manager: pinpointing exactly where performance is slipping

For portfolios spanning multiple markets, property types, and unit sizes, finding the specific segment dragging down performance has meant manually pulling data and cross-referencing market comps across spreadsheets and multiple dashboards.

Performance Manager replaces that process with a single view: a color-coded matrix that segments portfolio performance against market and year-over-year benchmarks, so property managers can see at a glance where they're winning and where they're not. Clicking into any segment drills down by market, bedroom count, or listing group to isolate the exact group underperforming, and routes directly into Beyond's Pricing Dashboard with that segment's filters already applied, turning diagnosis into action in a few clicks instead of a spreadsheet exercise.

A platform-wide update, more than 40 features deep

Beyond has also launched over 40 additional product and feature updates across the full platform over the past 6 months.

Beyond's dynamic pricing engine is more advanced than ever with the introduction of industry-first factors and customizations like Reputation Factor, Rebook Protection, Listing Benchmark Factor, Occupancy-Based Pricing, and more, all designed to further sharpen the algorithm while reducing the need for constant manual intervention. Additionally, the all-new Auto Base Price and Emergency Brake customizations give managers more built-in guardrails without additional monitoring, while seasonal time-based gap fills and length-of-stay pricing extend that same logic to help property managers and hosts offer more booking options to guests.

Consumer search demand also gets a makeover in Beyond's Insights with the new Search Insights dashboard that allows Beyond customers to get access to market-level web search data to understand more about how their guests travel. Automatic Comp Sets help save time when building out property benchmarking reports by providing initial recommendations for a comp, and new performance metrics provide additional details into the "why" behind a price recommendation or performance report.

Beyond's Tally payment processor now features easy-to-read monthly statements and an AI-powered dispute center that helps cut down the manual reconciliation and back-and-forth that payment disputes usually require. Signal, Beyond's direct booking platform, adds map-driven listing search, making it easier for guests to find and book directly. Beyond has also expanded its PMS integrations with Resly, PropertyStack, SuiteClerk, and Boom, with Evivvo coming soon, allowing professional property managers to take their dynamic pricing to another level.

Core platform updates round out the update: a redesigned homepage, a compact grid view, listing groups, a history tab, revenue goals, and more help property managers and hosts save time while getting access to advanced revenue management strategies. Together, these mean fewer clicks, easier strategy updates across large portfolios, and customizations that work to add peace of mind while saving time.

About Beyond

Trusted by thousands of short-term rental operators to price millions of listings, Beyond's dynamic pricing, market intelligence, and automated revenue management tools are built around one goal: to help every portfolio outperform the market by more than 20%. Beyond gives every operator, from the individual host to the enterprise property manager, the intelligence and control to run a more empowered, more profitable short-term rental business. Learn more at beyondpricing.com.

SOURCE Beyond

Share this article

TORONTO, Oct. 1, 2026 /PRNewswire/ -- Mayfair Gold Corp. ("Mayfair" or the "Company") (TSXV: MFG) (NYSE American: MINE) is pleased to announce that it has entered into a subscription agreement in connection with a strategic equity investment of C$10 million and an engagement letter and non-binding term sheet with Macquarie Bank Limited ("Macquarie") for a proposed C$300 million project finance facility (the "Facility"), for a total proposed financing package of up to C$310 million. The financing would support development of Mayfair's 100%-owned Fenn-Gib Gold Project ("Fenn-Gib" or the "Project") in the Timmins region of Northern Ontario.

Highlights

- Equity investment – Macquarie has entered into a subscription agreement for C$10 million of Mayfair common shares, priced at $C4.26, representing a 10% premium to the 5-day VWAP, aligning a leading global resources bank with Mayfair's shareholders.

- Project finance facility - non-binding engagement letter to arrange a C$300 million project finance facility (inclusive of up to C$20 million capitalized interest) which, if completed on the terms contemplated, would fund the majority of the C$450 million initial development capital estimated in the 2026 Pre-Feasibility Study.

- Early draw feature – the proposed Facility includes a C$25 million early drawdown tranche expected to be available on closing, which would provide financial flexibility to fund early works, long-lead equipment purchases and detailed engineering ahead of full construction drawdowns.

- Interest rate – Adjusted Term Canadian Overnight Repo Rate Average "CORRA" plus 4.75% per annum, stepping down to Adjusted Term CORRA plus 4.25% per annum following project completion, with up to C$20 million of interest capitalizable during construction.

- Repayment terms aligned with the mine plan – quarterly repayments would commence six months after the start of commercial production, with full repayment no later than 72 months after initial drawdown of the Facility following the early drawdown tranche.

- Gold offtake – the financing package includes an offtake right in favour of Macquarie over the first 50,000 ounces of gold produced each year, to a maximum of 300,000 ounces, priced at a published reference price less US$50 per ounce, with 50% of such gold offtake vesting concurrently with signing of the engagement letter and closing of Macquarie's equity investment and the remaining 50% of such gold offtake vesting on closing of the Facility.

Under the non-binding term sheet, Macquarie would act as Mandated Lead Arranger, Agent and Sole Underwriter of the Facility, which would be structured as a project finance facility. The proceeds would be used to partially fund the development, construction, commissioning and start-up of Fenn-Gib, together with associated working capital and project costs. The Facility would be secured by first-ranking security over the Project. Macquarie may, in consultation with Mayfair, arrange participation by additional lenders or risk participants in respect of a minimum of 30% of the Facility amount.

Kevin Annett, Mayfair's Chief Financial Officer, stated: "Entering into this engagement letter and financing term sheet represents an important milestone for Mayfair as we advance Fenn-Gib toward development. We are pleased to partner with Macquarie, a highly respected global financial institution with deep mining sector experience. The proposed financing provides a strong foundation for our broader project funding strategy while allowing us to maintain a disciplined approach to capital allocation and project execution. We believe Macquarie will be an excellent long-term partner as we advance Fenn-Gib and continue to grow the Company."

Mike Burns, Head of Mining Finance – Americas in Macquarie's Commodities and Global Markets business, added: "Fenn-Gib stands out as a Canadian gold project with the potential to become a significant new producer. Mayfair has taken a disciplined approach to advancing and de-risking the project, and we are pleased to bring Macquarie's global mining and project finance experience to support the next stage of its development. As a shareholder and through our engagement on the senior debt financing, we look forward to working with the Mayfair team as it advances Fenn-Gib towards construction and production."

The term sheet is non-binding. The proposed Facility and related transactions remain subject to completion of due diligence, including review by an independent engineer, negotiation and execution of definitive documentation, and satisfaction of conditions precedent customary for a financing of this nature.

The C$10 million strategic equity investment will be priced at C$4.26, representing a 10 percent (10%) premium to the 5-day volume-weighted average trading price of the Company's common shares on the TSX Venture Exchange on and including September 30, 2026, subject to Exchange approvals.

About Mayfair Gold

Mayfair Gold is a Canadian development-stage gold company focused on advancing the 100%-owned Fenn-Gib Project in the Timmins region of Northern Ontario. Fenn-Gib hosts a 4.3-million-ounce indicated mineral resource of gold (181.3Mt at an average grade of 0.74 g/t) and the expected strategy outlined in the 2026 Pre-Feasibility Study (the "PFS")1 is to develop the Project under the provincial permitting process, targeting the higher-grade 1-million-ounce probable mineral reserve (25.1Mt at an average grade of 1.29g/t) sitting near-surface, highlighting the optionality and scalability provided by the deposit. The PFS also outlines the potential to develop Fenn-Gib into a new Canadian gold producer, with initial development capital of C$450 million, a base-case payback period of 2.7 years, and cumulative free cash flow2 of US$896 million over the first six years of production based on a US$3,100/oz gold price. The Company is advancing permitting activities, detailed engineering, and stakeholder engagement with the goal of starting construction in 2028 with initial production in 2030. The Company also remains focused on exploration around the broader land package with the goal of enhancing mineral resource scale and growth opportunities.

Cautionary Note Regarding Forward-Looking Information

This news release contains certain forward-looking information within the meaning of applicable Canadian securities legislation and forward-looking statements within the meaning of applicable United States securities legislation (collectively, "forward-looking information"). The use of the words "will" and "expected" and similar expressions is intended to identify forward-looking information. Forward-looking information in this news release includes, but is not limited to, the expected strategy to develop the project under the provincial permitting process, targeting the higher-grade 1-million-ounce mineral reserve, building and operating the Fenn-Gib Project, any anticipated permitting timelines, the completion of the proposed financing with Macquarie on the terms described in this news release or at all, the availability, size, structure, pricing, drawdown and repayment of the project finance facility and the early draw tranche, the completion of the proposed equity investment and gold offtake, the sufficiency of the financing package relative to estimated development capital, and all disclosure related to the PFS, including expected commencement of construction and production. Although Mayfair Gold believes that the expectations reflected in such forward-looking information is reasonable, readers are cautioned that actual results may vary from the forward-looking information. The Company has based the forward-looking information on the Company's current expectations and assumptions about future events. This information also involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information, including the risks, uncertainties, and other factors identified in the annual information form and Form 40-F of the Company for the year ended December 31, 2025, available under the Company's profiles on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov, respectively. Furthermore, the forward-looking information contained in this news release is as at the date of this news release, and Mayfair does not undertake any obligation to publicly update or revise any of this forward-looking information except as may be required by applicable securities laws.

Neither the TSX Venture Exchange ("TSXV") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Mayfair Gold Corp.

Share this article

Siip Launches Free App and Personalized Subscription to Help Coffee Drinkers Understand Their Taste

Siip's subscription makes it easy for people to discover coffees matched to their evolving taste from roasters committed to long-standing partnerships with farmers.

SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Today Siip Coffee announced a personalized coffee app and subscription built to remove the guesswork from buying new coffee. Siip learns from every coffee a person drinks and rates, building a Taste Profile that evolves over time. The subscription sends coffees matched to each subscriber's taste and selected to encourage discovery.

The experience of "I know what I like when I taste coffee, but I couldn't tell you what I like about it" is reflected in Siip's data. Siip users most often say they prefer chocolate and nutty flavors in an onboarding survey. Across tens of thousands of ratings, those two flavors are consistently outperformed by less "familiar" flavor categories like floral and berries. Roast profile tells a similar story: six in ten users say they prefer medium roast, yet they rate lighter roasts higher.

"Our goal is to help coffee drinkers better understand their taste, to go from 'I like this' to 'I'm starting to understand why,'" said Nick Spilger, founder and CEO of Siip Coffee. "We built Siip around the idea that people shouldn't have to become coffee experts before they can explore great coffee."

Siip considers factors such as origin, variety, processing method, roast level, and flavor profile across tens of thousands of coffees, while keeping the experience simple. Users can rate any coffee, whether it's from their Siip subscription, a cafe, or a grocery shelf. They scan the bag and answer one question: "How was this coffee?" Every rating sharpens their Taste Profile and the coffees the subscription picks next.

Richie Seaberry, a Siip subscriber, said: "If you asked me six months ago what coffees I like, my answer would have been dark roast with a bunch of cream. Now, I'd tell you it's probably somewhere from Nicaragua, probably a medium roast, with notes of nuts or chocolate."

Every shipment aligns with a subscriber's taste preferences while inviting them to discover something new. Siip might send two coffees from the same country with different processing methods, so a subscriber can taste how processing shapes flavor.

The coffees come from Siip's founding roaster partners, who share a commitment to long-standing relationships with farmers. Many, including Onyx Coffee Lab, Equator Coffees, George Howell Coffee, Cat & Cloud, and Joe Coffee, have worked with the same farmers for years, sometimes decades. These relationships enable roasters and farmers to invest more deeply in quality and in the long-term viability of their businesses and communities. Siip picks from each roaster's full catalog, so limited releases and rare single origins go to the subscribers whose taste they match.

The Siip app is free and available worldwide on iOS and Android. The personalized subscription is available in the United States, starting at $14.40 per bag of whole beans for the first two months and $18 per bag thereafter, with free shipping. Subscribers can skip, pause, or cancel anytime.

About Siip Coffee

Siip is a specialty coffee app and subscription that helps people understand what good coffee means to them. Its free app and personalized subscription combine individual preferences with coffee data to help people explore the world of coffee. Siip is an official partner of the Cup of Excellence and donates a portion of its revenue toward farmer development programs through its partnership with Enveritas. Founded in 2024. Learn more at siip.coffee.

SOURCE Siip Coffee

Share this article

Funding brings Armadin's valuation to over $2.5 billion just seven months after its launch as AI compresses the time between vulnerability discovery and exploitation

PALO ALTO, Calif., Oct. 1, 2026 /PRNewswire/ -- Armadin, an AI-native cybersecurity company building effective autonomous security, today announced it has raised $255.5 million in Series B funding co-led by Andreessen Horowitz (a16z) and Accel that brings the company's valuation to over $2.5 billion. The round includes participation from new investors Bain Capital Ventures (BCV) and Redpoint. Existing investors 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures also returned, reflecting their continued confidence, bringing Armadin's total funding to $445 million.

Seven months after emerging from stealth, Armadin is running agentic attack campaigns in production for Fortune 500 enterprises and government customers. As frontier AI models compress the time between vulnerability disclosure and working exploit, periodic penetration tests cannot keep pace. Scanner output fails in a different way, because it scores each finding in isolation. Armadin deploys an autonomous swarm of specialized agents that reason like a skilled adversary across the attack surface, chaining individually low-severity weaknesses into validated kill chains. Those chains run from unauthenticated remote code execution at the perimeter through lateral movement to full cloud compromise. Enterprise and government security teams see the exact attack paths an adversary would use in production today, along with the blast radius of each, and sever them before they are exploited.

"Offense is uniquely advantaged right now," said Kevin Mandia, CEO of Armadin. "AI lets an attacker find and chain weaknesses faster than any human team can respond. The only way to build a defense that keeps pace is to train it against the best offense available, every day. That is what we built. With a16z and Accel co-leading and the support of every investor in this round, we are going to put that offense to work for the enterprises and government agencies defending the world's most critical systems."

Armadin will use the investment to scale its agentic security platform, and to scale its research, training, and go-to-market efforts.

"Against agentic adversaries, the best defense is a great offense powered by AI. That was our conviction when we led Armadin's Series A, and it's even more pressing today," said Ping Li, Partner at Accel. "In less than a year, Armadin has set the standard for AI-powered offensive security and remediation across enterprises and governments, and we're excited to keep partnering with them."

"Every major platform shift creates a new generation of security leaders, and AI is the biggest shift we've seen," said David George, General Partner at Andreessen Horowitz. "Kevin has been on the front lines of the most consequential breaches in history, and he has built a team that pairs elite red teamers with world-class AI engineers. We invested because we believe Armadin will become the defining security company of the AI era."

About Armadin

Armadin is an AI-native cybersecurity company delivering the definitive offensive security platform to identify and eliminate an organization's exploitable risks. As the threat of AI-driven threats escalates, Armadin empowers enterprises to proactively secure their environments. Armadin's platform safely delivers the most comprehensive and powerful AI Hyperattacks to identify new and novel attack paths before adversaries can exploit them. Led by CEO Kevin Mandia, Armadin is a group of engineers, researchers, and hackers on a mission to create effective autonomous security.

For more information, visit www.armadin.com.

Media Contacts

Armadin  |  Kristy Campbell  |  [email protected]

SOURCE Armadin

Share this article